Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AVCN |
---|---|---|
09:32 ET | 3000 | 0.32 |
10:10 ET | 2000 | 0.32 |
10:17 ET | 11000 | 0.29 |
10:30 ET | 2000 | 0.3 |
11:00 ET | 2000 | 0.31 |
11:02 ET | 500 | 0.305 |
12:48 ET | 6500 | 0.31 |
12:56 ET | 2500 | 0.31 |
12:59 ET | 25500 | 0.3 |
02:00 ET | 4000 | 0.3 |
02:02 ET | 500 | 0.3 |
03:02 ET | 3500 | 0.295 |
03:23 ET | 1000 | 0.3 |
03:39 ET | 7000 | 0.3 |
03:43 ET | 1500 | 0.305 |
03:59 ET | 1000 | 0.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Avicanna Inc | 35.5M | -3.8x | --- |
Microbix Biosystems Inc | 43.1M | 11.5x | --- |
Immunoprecise Antibodies Ltd | 22.7M | -1.0x | --- |
Aeterna Zentaris Inc | 28.9M | -0.4x | --- |
Medicure Inc | 13.1M | -9.8x | --- |
Numinus Wellness Inc | 12.7M | -0.5x | --- |
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patients’ needs and enhances the patient's journey.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $35.5M |
---|---|
Revenue (TTM) | $22.1M |
Shares Outstanding | 109.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-0.08 |
Book Value | $0.00 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -31.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.